BioLight Life Sciences Ltd (BOLT)

Currency in ILS
239.0
+0.3(+0.13%)
Delayed Data·
BOLT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
238.9239.0
52 wk Range
209.2636.7
Key Statistics
Bid/Ask
233.50 / 239.00
Prev. Close
238.7
Open
239
Day's Range
238.9-239
52 wk Range
209.2-636.7
Volume
5K
Average Vol. (3m)
21.74K
1-Year Change
-59.1267%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BOLT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

BioLight Life Sciences Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Mar 15, 2026
EPS / Forecast
-0.36 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

BOLT Income Statement

Compare BOLT to Peers and Sector

Metrics to compare
BOLT
Peers
Sector
Relationship
P/E Ratio
−1.8x−1.1x−0.5x
PEG Ratio
0.06−0.010.00
Price / Book
0.6x1.2x2.6x
Price / LTM Sales
-1.6x3.3x
Upside (Analyst Target)
-323.7%47.7%
Fair Value Upside
Unlock15.6%6.6%Unlock

BioLight Life Sciences Ltd. engages in the investment, development, management, and commercialization of products in the fields of advanced medical devices, pharmaceuticals, diagnostics, and digital medicine in Israel. The company offers TeaRx, a diagnostic platform intended for point-of-care testing of ophthalmic pathologies through multi-parameter composition analysis of the tear fluid; TeaRx Dry Eye Syndrome; and Ocuvia, a front-to-back ocular treatment that includes ocudrip and ocugrid. It also provides Eye-D technology which treats glaucoma by the insertion of a sub-conjunctival implant; and Ocular D, a product for treating dryness in the eye with integrated vitamin D. In addition, the company engages in the development of drugs for treating eye diseases using a technological platform that enhances the transmission of active substances based on nanostructures. The company was formerly known as Bio Light Israeli Life Sciences Investments Ltd. and changed its name to BioLight Life Sciences Ltd. in February 2016. BioLight Life Sciences Ltd. was incorporated in 2005 and is based in Ramat Gan, Israel.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
506.77K5.60%1.21M
Other Institutional Investors
2.27M25.08%5.42M
Public Companies & Retail Investors
6.27M69.32%14.97M
Total
9.05M100.00%21.6M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Rock-One International Holdings Ltd9.57%865,6472,066
Sun Pharmaceutical Industries Limited7.14%646,0261,542

FAQ

What Is the Bio Light (BOLT) Stock Price Today?

The Bio Light stock price today is 239.0 ILS.

What Stock Exchange Does Bio Light Trade On?

Bio Light is listed and trades on the Tel Aviv Stock Exchange.

What Is the Stock Symbol for Bio Light?

The stock symbol for Bio Light is "BOLT."

What Is the Bio Light Market Cap?

As of today, Bio Light market cap is 21.67M ILS.

What Is Bio Light's Earnings Per Share (TTM)?

The Bio Light EPS (TTM) is -2.0.

From a Technical Analysis Perspective, Is BOLT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Bio Light Stock Split?

Bio Light has split 4 times.

How Many Employees Does Bio Light Have?

Bio Light has 4 employees.

What is the current trading status of Bio Light (BOLT)?

As of May 04, 2026, Bio Light (BOLT) is trading at a price of 239.0 ILS, with a previous close of 238.7 ILS. The stock has fluctuated within a day range of 238.9 ILS to 239.0 ILS, while its 52-week range spans from 209.2 ILS to 636.7 ILS.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.